Stock vs Stock Comparison

Beam Therapeutics Inc. vs Absci Corporation

BEAM wins the Tale of the Tape 7–1.

BEAM$29.55
ABSI$5.94

🏆 Tale of the Tape

71
BEAMABSI
-57.2%Profitability (Net Margin)-4113.7%
-21.9%Efficiency (ROIC)-46.9%
3/9Health (Piotroski F)2/9
5.5Safety (Altman Z)5.1
120.0%Growth (Rev YoY)-38.2%
1.12Risk (Sharpe 1Y)0.56
0.20xBalance Sheet (D/E)0.14x
-14.41%FCF Yield-21.57%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.483
252-Day Correlation
0.479
126-Day Correlation

Moderately correlated — some diversification benefit from holding both.

Fundamentals

MetricBEAMABSI
Market Cap$3.4B$1.1B
P/E Ratio
Forward P/E-6.9x-10.6x
P/B2.81x6.10x
Dividend Yield
Beta2.262.38

Quantitative Metrics

MetricBEAMABSI
DCF Fair Value
DCF Upside
Piotroski F3/92/9
Altman Z5.545.11
Beneish M
FCF Yield-14.41%-21.57%
Net Debt/EBITDA
ROIC-21.9%-46.9%
WACC
ROIC – WACC
Gross Margin
Net Margin-57.2%-4113.7%
Rev Growth YoY120.0%-38.2%
Sharpe (1Y)1.120.56
Max Drawdown 3Y-67.7%-66.1%
FCF Payout Ratio

BEAM Price

Loading chart...

ABSI Price

Loading chart...

ETF Exposure

BEAM found in:

ARKG4.83%
ARKK2.76%
XBI1.23%
VBK0.09%
VTWO0.09%
VHT0.04%

ABSI found in:

ARKG4.81%
XBI0.32%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

BEAM vs ABSI: Head-to-Head Analysis

Beam Therapeutics Inc. (BEAM) and Absci Corporation (ABSI) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, BEAM leads 7–1 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, BEAM generates a return on invested capital (ROIC) of -21.9% compared to ABSI's -46.9%. This suggests BEAM is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between BEAM and ABSI is 0.483, indicating moderate co-movement, with some diversification value from holding both in a portfolio context.

BEAM appears in 6 ETFs tracked by SecuritiesDB, while ABSI appears in 2 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, BEAM or ABSI?

Our quantitative analysis compares BEAM and ABSI across nine fundamental dimensions. BEAM wins the Tale of the Tape 7–1. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are BEAM and ABSI correlated?

The 252-day correlation between BEAM and ABSI is 0.483. They show moderate correlation — partially diversifying.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.